O2 Transport and Utilization in Health and Lung Disease

NCT04014712 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to recruit due to COVID-19 pandemic

Conditions

COPD
Tetrahydrobiopterin Deficiency
Oxidative Stress

Interventions

DRUG: Tetrahydrobiopterin
DRUG: Placebo oral tablet

Sponsor

University of Massachusetts, Amherst